Subgroup survival analysis showed high baseline IL-8 was associated with a significantly worse prognosis in SCLC but not NSCLC, with an HR for progression of 1.94 (95% CI 1.05–3.59; P=0.036). This evidence concerns the gene CXCL8 and non-small cell lung carcinoma.